首页> 美国卫生研究院文献>Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America >5-Year Prospective Evaluation of Cytology Human Papillomavirus Testing and Biomarkers for Detection of Anal Precancer in Human Immunodeficiency Virus–Positive Men Who Have Sex With Men
【2h】

5-Year Prospective Evaluation of Cytology Human Papillomavirus Testing and Biomarkers for Detection of Anal Precancer in Human Immunodeficiency Virus–Positive Men Who Have Sex With Men

机译:对人类免疫缺陷病毒阳性男性进行细胞学人类乳头瘤病毒测试和生物标记物检测肛门癌的5年前瞻性评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human papillomavirus (HPV)-related biomarkers have shown good cross-sectional performance for anal precancer detection in human immunodeficiency virus–positive (HIV+) men who have sex with men (MSM). However, the long-term performance and risk stratification of these biomarkers are unknown. Here, we prospectively evaluated high-risk (HR) HPV DNA, HPV16/18 genotyping, HPV E6/E7 messenger RNA (mRNA), and p16/Ki-67 dual stain in a population of HIV+ MSM.
机译:与人类乳头瘤病毒(HPV)相关的生物标记物在与男性发生性关系的人类免疫缺陷病毒阳性(HIV +)男性中显示出良好的横截面性能,可用于肛门癌前检测。然而,这些生物标记物的长期表现和风险分层尚不清楚。在这里,我们前瞻性评估了HIV + MSM人群中的高风险(HR)HPV DNA,HPV16 / 18基因分型,HPV E6 / E7信使RNA(mRNA)和p16 / Ki-67双重染色。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号